탁원영 프로필 사진

탁원영

Tak Wonyoung

의과대학

의학과

Web Of Science Scopus ORCID

자료 필터

자료유형

발행연도

2022 ~ 2025
2022 2025

키워드

언어

전체 61건 중 31번부터 40번까지의 결과를 표시합니다.

2023
Article

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3trial

  • Qin, Shukui ; 
  • Chen, Minshan ; 
  • Cheng, Ann-Lii ; 
  • Kaseb, Ahmed ; 
  • Kudo, Masatoshi ; 
  • ... Tak, Won Young ; 
  • 외 18명
  • 2023-11-18
  • The Lancet
  • ELSEVIER SCIENCE INC
Article

IMbrave050: Phase 3 study of adjuvant atezolizumab plus bevacizumab versus active surveillance in patients with hepatocellular carcinoma (HCC) at high risk of disease recurrence following resection or ablation

  • Trojan, J. ; 
  • Chow, P. ; 
  • Chen, M. ; 
  • Cheng, A-L ; 
  • Kaseb, A. ; 
  • ... Tak, W-Y ; 
  • 외 17명
  • 2023-10-03
  • Oncology Research and Treatment
  • KARGER
Article

Tissue Circular RNA_0004018 and 0003570 as Novel Prognostic Biomarkers for Hepatitis B-Related Hepatocellular Carcinoma

  • 2023-10
  • Genes
  • MDPI
Article

AN ARTIFICIAL INTELLIGENCE MODEL FOR PREDICTION OF HEPATOCELLULAR CARCINOMA DEVELOPMENT AFTER ORAL ANTIVIRAL THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C☆

  • 2023-10
  • Hepatology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

HCC PREDICTION MODELS EFFECTIVELY ASSESS THE RISK OF HCC IN CHRONIC HEPATITIS C PATIENTS WITHOUT ADVANCED FIBROSIS AFTER ORAL ANTIVIRAL THERAPY: A MULTICENTER STUDY

  • 2023-10
  • Hepatology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

REAL-WORLD EXPERIENCE OF ATEZOLIZUMAB PLUS BEVACIZUMAB COMBINATION TREATMENT IN HIGH-RISK PATIENTS WITH ADVANCED HEPATOCELLULAR CARCINOMA

  • 2023-10
  • Hepatology
  • LIPPINCOTT WILLIAMS & WILKINS
Article

ALT Is Not Associated With Achieving Subcirrhotic Liver Stiffness and HCC During Entecavir Therapy in HBV-Related Cirrhosis

  • 2023-08
  • Clinical Gastroenterology and Hepatology
  • ELSEVIER SCIENCE INC
Article

Efficacy and safety of sofosbuvir-velpatasvir and sofosbuvir-velpatasvir-voxilaprevir for hepatitis C in Korea: a Phase 3b study

  • Heo, Jeong ; 
  • Kim, Yoon Jun ; 
  • Lee, Sung Wook ; 
  • Lee, Youn-Jae ; 
  • Yoon, Ki Tae ; 
  • ... Tak, Won Young ; 
  • 외 19명
  • 2023-07
  • The Korean Journal of Internal Medicine
  • KOREAN ASSOC INTERNAL MEDICINE
Article

Real-world experience of atezolizumab plus bevacizumab combination treatment in high risk patients with advanced hepatocellular carcinoma

  • 2023-06
  • Journal of Hepatology
  • ELSEVIER